EI
TMO icon

Ellevest Inc’s Thermo Fisher Scientific TMO Stock Holding History

Ellevest Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$955K Sell
1,943
-212
-10% -$115K 0.13% 107
2025
Q4 		$1.25M Sell
2,155
-95
-4% -$53.7K 0.17% 81
2025
Q3 		$1.09M Buy
2,250
+433
+24% +$202K 0.16% 98
2025
Q2 		$737K Buy
1,817
+272
+18% +$114K 0.12% 130
2025
Q1 		$769K Buy
1,545
+188
+14% +$102K 0.05% 129
2024
Q4 		$706K Buy
1,357
+70
+5% +$38.5K 0.04% 146
2024
Q3 		$796K Sell
1,287
-38
-3% -$22.5K 0.04% 138
2024
Q2 		$733K Buy
1,325
+57
+4% +$32.7K 0.04% 139
2024
Q1 		$737K Buy
1,268
+756
+148% +$424K 0.05% 141
2023
Q4 		$272K Buy
512
+54
+12% +$26.1K 0.02% 312
2023
Q3 		$232K Sell
458
-33
-7% -$17.6K 0.02% 308
2023
Q2 		$256K Sell
491
-74
-13% -$39.9K 0.02% 295
2023
Q1 		$326K Sell
565
-837
-60% -$472K 0.03% 224
2022
Q4 		$772K Sell
1,402
-99
-7% -$52.5K 0.07% 75
2022
Q3 		$761K Buy
1,501
+123
+9% +$68.8K 0.07% 62
2022
Q2 		$749K Sell
1,378
-175
-11% -$96.3K 0.07% 69
2022
Q1 		$917K Buy
1,553
+339
+28% +$195K 0.08% 60
2021
Q4 		$810K Buy
1,214
+28
+2% +$17.5K 0.07% 64
2021
Q3 		$678K Sell
1,186
-16
-1% -$8.78K 0.07% 72
2021
Q2 		$606K Buy
1,202
+195
+19% +$92K 0.06% 74
2021
Q1 		$460K Buy
1,007
+126
+14% +$60.1K 0.06% 87
2020
Q4 		$410K Buy
881
+183
+26% +$85.8K 0.06% 77
2020
Q3 		$308K Buy
698
+113
+19% +$46.7K 0.06% 94
2020
Q2 		$212K Buy
585
+163
+39% +$54.6K 0.05% 111
2020
Q1 		$120K Buy
422
+157
+59% +$49.5K 0.03% 122
2019
Q4 		$86K Buy
265
+163
+160% +$49.4K 0.02% 120
2019
Q3 		$30K Buy
102
+7
+7% +$2K 0.01% 158
2019
Q2 		$28K Buy
95
+55
+138% +$15.1K 0.01% 179
2019
Q1 		$11K Hold
40
– – 0.01% 187
2018
Q4 		$9K Buy
+40
New +$9.38K ﹤0.01% 387

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellevest Inc's TMO Position: Q1 2026 in Review

Ellevest Inc reduced its Thermo Fisher Scientific (TMO) stake by 9.8% in Q1 2026, selling an estimated $115K and leaving 1,943 shares worth $955K. The position accounts for 0.13% of the portfolio, ranked #107.

Ellevest Inc first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.25M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Ellevest Inc held 1,943 shares of Thermo Fisher Scientific worth $955K as of Q1 2026.
  • Ellevest Inc sold 212 Thermo Fisher Scientific shares in Q1 2026, an estimated $115K.
  • Thermo Fisher Scientific made up 0.13% of Ellevest Inc's portfolio in Q1 2026, its #107 holding.
  • Ellevest Inc first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Ellevest Inc's Thermo Fisher Scientific position peaked at $1.25M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.